Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 147
Selected: 0
NCT IDTitle
NCT05079074Clinical Application of Circulating Tumor DNA (ctDNA) in Patients With Late-stage Breast Cancer
NCT03146455Thromboelastography Normal Reference Values in China Hunan Province
NCT01616849Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma
NCT06752798Bone Marrow Protective Effect of Trilaciclib in Postoperative CCRT for LA-HNSCC
NCT06840704Immunonutrition Reduces Acute Esophagitis After Thoracic Radiotherapy in Lung Cancer
NCT06022770Clinical Study on Nutrition Intervention in Patients With Esophageal and Gastric Cancer Treated With Chemotherapy
NCT07459296Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC
NCT05484375Capecitabine Plus Toripalimab Maintenance Therapy in Metastatic Nasopharyngeal Carcinoma After First-line Treatment
NCT06788002LDRT and Chemoimmunotherapy in NPC With Liver Metastasis
NCT05460481Anlotinib Plus Penpulimab in Advanced Non-Small-Cell Lung Cancer Previously Treated With PD-1/PD-L1 Inhibitors
NCT05980208A Real-world Study of Inetetamab for First-line Treatment of MBC
NCT04414969Anti-PD-1 Antibody Combined With Peg-Asparaginase and Chidamide for the Early Stage of NK/T Cell Lymphoma
NCT03895788A Study of Niraparib in Combination With Brivanib in Recurrent Ovarian Cancer
NCT07098026Shenqi Fuwei Mixture Combined With Chemotherapy Neoadjuvant Therapy for Locally Advanced Gastric Cancer
NCT06047184Phase I Study of BEBT-209 in Women With Advanced Breast Cancer
NCT05273944Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients
NCT03624309Anlotinib Plus Docetaxel for the Treatment of EGFR Wild-type Advanced Non-small-cell Lung Cancer
NCT05430399Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer
NCT04030845Patient Report Outcome-Reconstruction and Oncoplastic Cohort
NCT07209787SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak
NCT064924602 Courses of Concurrent Cisplatin Chemoradiotherapy After Surgery for High-risk Head and Neck Squamous Cell Carcinoma
NCT07176962A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening
NCT05351346Genotype-guided Treatment in DLBCL
NCT04826406A Study of Camrelizumab Combined Apatinib in Hepatocellular Carcinoma Previously Treated With Immune Checkpoint Inhibitors (ICIs).
NCT02891083Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer
NCT06836869Modified Tumor-free Techniques Operation to Cervical Cancer
NCT04136886Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma
NCT05598528Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)
NCT01271439Study of Chemoradiotherapy Combined With Cetuximab in Nasopharyngeal Carcinoma
NCT06440954Efficacy and Resistance Mechanisms of IP in NSCLC With Leptomeningeal Metastases
NCT04922567Efficacy and Safety of Lenalidomide Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma
NCT03880695Anlotinib Hydrochloride Combined With Liposomal Doxorubicin in the Treatment of Locally Advanced or Metastatic Soft Tissue Sarcoma
NCT05001971Anlotinib Plus Penpulimab as Second-line Treatment for Patients With Small Cell Lung Cancer After Failure of Platinum-based Chemotherapy
NCT02717923A Single Arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Maintenance Treatment With Capecitabine Plus Cetuximab in Metastatic Colorectal Cancer
NCT05872880TPExtreme Induced Chemotherapy Followed by Surgery and Radiotherapy in the Oral Carcinoma.
NCT06385990Utidelone (UTD1) Plus Capecitabine in Non-pCR TNBC After Neoadjuvant Therapy
NCT07590024RAIRI Model-Guided Adjuvant Therapy in Nasopharyngeal Carcinoma
NCT03066310Urine-DNA Biomarkers in Detecting Bladder Cancer
NCT01285219A Study Comparing Pegylated Filgrastim and Filgrastim in Support for Chemotherapy
NCT06321939Sequencing-based Counting of Plasma Epstein-Barr Virus DNA in Non-metastatic Nasopharyngeal Carcinoma
NCT07005999Interventional Ablation for Early-stage Lung Cancer
NCT06543108Preliminary Study on the Diagnostic Value Comparison of 18F-FAPI-04 PET/CT and PET/MR in Gastric Cancer
NCT04103853Safety, Tolerability, and Pharmacokinetics of Proxalutamide Therapy in Women With Metastatic Breast Cancer
NCT03503136Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC
NCT02395705Neoadjuvant Chemotherapy Versus Surgery Alone for Esophageal Squamous Cell Carcinoma
NCT06092957Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy
NCT05535413UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases
NCT04337632Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer
NCT07544056A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer
NCT07237828Drain Removal on Postoperative Safety and Patient Satisfaction in R-E-NSM With Prepectoral DIBR